The cannabis lobby is reorganizing itself: from now on, the Cannabis Industry Association (BvCW) will represent the interests of the young economic sector. DRAPALIN is active on the board as a founding member.
The World Drug Report is an annual publication of the United Nations Office on Drugs and Crime that analyses the global drug market and its societal impacts. The third booklet of the 2022 report, entitled "Drug Market Trends of Cannabis and Opioids", is the only section that deals with medical cannabis.
DRAPALIN became a supporting member of the Association of Cannabis providing pharmacies (VCA) e. V.
According to its own information, Drapalin will cooperate with Coliquio, the largest German-language information platform for doctors. For the first time, 190,000 physicians will have a new opportunity to obtain practical knowledge on the topic of medical cannabis and to exchange information together.
Drapalin now distributes PAX Labs 3 vaporizers in Germany and Demecan announces three new supply contracts. Our product update for the medical cannabis market.
Cosmopolitan magazine interviewed our CEO Lana Korneva in the March issue under the motto #SupportHer. With this monthly series, Cosmopolitan presents inspiring women. Why the Drapalin co-founder and CEO traded her successful financial career for one of the world's oldest medicinal plants, read here.
Munich - Since 2021, German pharmacies can rely on the stable and secure supply of medical cannabis from the experienced Munich-based wholesaler DRAPALIN. Orders for DRAPALIN cannabis flowers can be placed both directly with Drapalin Pharmaceuticals GmbH and, as of now, with pharmaceutical wholesalers Alliance Healthcare Deutschland GmbH and GEHE Pharma Handel GmbH.
The Ukrainian Ivan Garev, one of the founders of Drapalin, has been taking care of aid packages being sent to Ukraine since the beginning of the war. A special call directly from the war zone is crucial for our CBD oil aid package, which is already on its way to Ukraine.
DRAPALIN is now cooperating with coliquio, the largest German-language information platform for doctors. For the first time, 190,000 physicians have an exclusive opportunity to obtain practical knowledge on the topic of medical cannabis and to exchange information together.
Medical cannabis – drapalin is working on a non-interventional study on cannabis therapy for adhd and is asking interested doctors to participate.
Munich - Medical cannabis has already established itself as a therapy option for many clinical indications. Nevertheless, there are still many areas of application in which numerous patients are successfully treated with cannabis, but this has so far received little attention in research.
Berlin - Cannabis is playing an increasingly important role in pharmacies. In the past few years, new suppliers have joined the ranks. They all cultivate cannabis in pharmaceutical quality. The location and the type of cultivation influence the end product.
Medical cannabis is considered a field of hope for German start-ups. However, demand still exceeds supply. More and more companies are nevertheless entering the market.